My watch list
my.bionity.com  
Login  

Adalimumab

News Adalimumab

All news on adalimumab

Publications Adalimumab

All publications on adalimumab
Definition

Adalimumab

Adalimumab Adalimumab (brand name Humira) is the third TNF antagonist, after infliximab and etanercept , to be approved in the U.S. Like infliximab and etanercept, adalimumab binds to TNFα , preventing it from activating TNF receptors; adalim ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE